Orexin Receptor Antagonists [MoA] - N0000190998
Pharmacologic Class Information
Pharmacologic Code | N0000190998 |
Pharmacologic Name | Orexin Receptor Antagonists |
Pharmacologic Uses |
|
Pharmacologic Concept | Mechanisms of Action - [MoA] |
Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Orexin Receptor Antagonists
The following table contains 9 products whose active ingredient are classified under the same pharmacologic class Orexin Receptor Antagonists [MoA].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0006-0005 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
0006-0033 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
0006-0325 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
0006-0335 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
62856-405 | Dayvigo | Non-Proprietary Name: Lemborexant | Tablet, Film Coated | Oral | Eisai Inc. | ACTIVE | |
62856-410 | Dayvigo | Non-Proprietary Name: Lemborexant | Tablet, Film Coated | Oral | Eisai Inc. | ACTIVE | |
62856-455 | Dayvigo | Non-Proprietary Name: Lemborexant | Tablet, Film Coated | Oral | Eisai Inc. | ACTIVE | |
80491-7825 | Quviviq | Non-Proprietary Name: Daridorexant | Tablet, Film Coated | Oral | Idorsia Pharmaceuticals Ltd | ACTIVE | |
80491-7850 | Quviviq | Non-Proprietary Name: Daridorexant | Tablet, Film Coated | Oral | Idorsia Pharmaceuticals Ltd | ACTIVE |